{"id":123,"date":"2019-02-12T13:30:00","date_gmt":"2019-02-12T13:30:00","guid":{"rendered":"https:\/\/nolato.wpengine.com\/?mfn_news=nolato-year-end-report-strong-financial-position-and-proposed-increase-in-dividend"},"modified":"2019-02-12T13:30:00","modified_gmt":"2019-02-12T13:30:00","slug":"nolato-year-end-report-strong-financial-position-and-proposed-increase-in-dividend","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/es\/mfn_news\/nolato-year-end-report-strong-financial-position-and-proposed-increase-in-dividend\/","title":{"rendered":"Nolato year-end report:\u00a0Strong financial position and proposed increase in dividend"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/strong><\/div>\n<p><span><strong>Fourth quarter of 2018:<\/strong><br \/><\/span><\/p>\n<ul>\n<li><span>Sales totalled SEK 1,781 million (1,926)<\/span><\/li>\n<li><span>Operating profit (EBITA) was SEK 214 million (230)<\/span><\/li>\n<li><span>EBITA margin of 12.0% (11.9)<\/span><\/li>\n<li><span>Profit after tax was SEK 158 million (180)<\/span><\/li>\n<li><span>Basic earnings per share were SEK 6.01 (6.84)<\/span><\/li>\n<li><span>Cash flow after investment was SEK 122 million (157)<\/span><\/li>\n<\/ul>\n<p>Medical Solutions sales for the fourth quarter increased to SEK 580 million (511). Adjusted for currency, sales increased by a strong 8%. Operating profit (EBITA) rose to SEK 77 million (68). The EBITA margin was 13.3% (13.3).<\/p>\n<p><span>\u201cSales increased in both Medical Devices and Pharma Packaging,\u201d said Nolato President and CEO Christer Wahlquist. \u201cActivity remains high in Nolato\u2019s market, with project activity primarily in autoinjectors for biological medication, insulin products and incontinence products.\u201d<\/span><\/p>\n<p><span>Integrated Solutions sales for the fourth quarter decreased to SEK 703 million (900); adjusted for currency, the decrease was 27%. Operating profit (EBITA) decreased to SEK 99 million (116). The EBITA margin grew to a very strong 14.1% (12.9). The margin was boosted by 2.0 percentage points from the receipt of compensation from Chinese authorities.<\/span><\/p>\n<p><span>\u201cAs announced, inventory adjustments in Heating Devices had a negative impact on sales in the quarter,\u201d noted Christer Wahlquist. \u201cWe assess that volumes will be at a markedly lower level for the first six months of 2019, compared with the rate in the fourth quarter of 2018, pending the launch of new models. Nolato has received orders for the new models and retains a strong position with the customer.\u201d<\/span><\/p>\n<p>Industrial Solutions sales decreased to SEK 505 million (518); adjusted for currency and Group structure, the decrease was 4%. Operating profit (EBITA) decreased to SEK 39 million (52) and the EBITA margin to 7.7% (10.0).<\/p>\n<p><span>\u201cProduction volumes were at a similar level as the previous year taken over the entire quarter, while invoicing of development work and production equipment was slightly lower,\u201d said Christer Wahlquist. \u201cThe weak margin was due to continued unsatisfactory efficiency in automotive and low volumes prior to the Christmas break.\u201d<\/span><\/p>\n<p><span>Today\u2019s year-end report for 2018 shows the best ever year in Nolato\u2019s history.<\/span><\/p>\n<p><span><strong>Full year 2018:<\/strong><br \/><\/span><\/p>\n<ul>\n<li>Sales rose by 21% to SEK 8,102 million (6,720)<\/li>\n<li>Operating profit (EBITA) increased sharply to SEK 949 million (763)<\/li>\n<li>Basic earnings per share increased to SEK 27.44 (21.74)<\/li>\n<li>The equity\/assets ratio was 50% (45) and net financial assets were SEK 159 million (\u2212153)<\/li>\n<li>The Board of Directors proposes an increased dividend with 12% of SEK 14.00 (12.50) per share<\/li>\n<\/ul>\n<p><span>Adjusted for currency and Group structure, sales rose by an exceptionally strong 17%.<\/span><\/p>\n<p>Medical Solutions sales rose to SEK 2,270 million (1,955), which, adjusted for currency, is a strong increase of 12%. Operating profit (EBITA) increased to SEK 295 million (257) and the EBITA margin to 13.0% (13.1).<\/p>\n<p>Integrated Solutions sales rose to SEK 3,720 million (2,810). Adjusted for currency, this was an\u00a0exceptionally strong increase of 28%. Operating profit (EBITA) rose sharply to SEK 473 million (332)\u00a0and the EBITA margin was a strong 12.7% (11.8).<\/p>\n<p>Industrial Solutions sales totalled SEK 2,119 million (1,968). Adjusted for currency and Group structure,\u00a0growth was a healthy 6%. Operating profit (EBITA) was SEK 186 million (195), with an EBITA margin\u00a0of 8.8% (9.9).<\/p>\n<p>Nolato retains a healthy financial position, with an equity\/assets ratio of 50% (45) and net financial\u00a0assets of SEK 159 million (net financial liabilities of SEK \u2013153 million). The Board proposes an increase\u00a0in the dividend to SEK 14.00 (12.50).<\/p>\n<p><span>The Annual General Meeting will be held on 8 May 2019 at 4 p.m. CET in Grevie, Sweden.<\/span><\/p>\n<p><span>&#8212;&#8212;&#8212;<br \/><em>For further information, please contact:<\/em><br \/><em>Christer Wahlquist, President and CEO, +46 (0)705 804848<\/em><br \/><em>Per-Ola Holmstr\u00f6m, CFO, +46 (0)705 763340<\/em><\/span><\/p>\n<p><em>Nolato is a Swedish group with operations in Europe, Asia and North America. We develop and manufacture\u00a0products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology,\u00a0pharmaceuticals, telecom, automotive, hygiene and other selected industrial sectors. Nolato\u2019s shares are listed on\u00a0Nasdaq Stockholm in the Large Cap segment, where they are included in the Industrials sector.<\/em><\/p>\n<p><em><span>This information is information that Nolato AB is obliged to publish pursuant to the EU Market Abuse Regulation\u00a0and the Swedish Securities Market Act. The information was issued for publication by the above contact person on\u00a012 February at 2.30 p.m. CET.<\/span><\/em><\/p>\n<p><em><span>www.nolato.com<\/span><\/em><\/p>\n<div class=\"mfn-footer\">\n<p><span><strong><\/strong><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Fourth quarter of 2018: Sales totalled SEK 1,781 million (1,926) Operating profit (EBITA) was SEK 214 million (230) EBITA margin of 12.0% (11.9) Profit after tax was SEK 158 million (180) Basic earnings per share were SEK 6.01 (6.84) Cash flow after investment was SEK 122 million (157) Medical Solutions sales for the fourth quarter&hellip; <a class=\"more-link\" href=\"https:\/\/temporary.nolato.com\/es\/mfn_news\/nolato-year-end-report-strong-financial-position-and-proposed-increase-in-dividend\/\">Continue reading <span class=\"screen-reader-text\">Nolato year-end report:\u00a0Strong financial position and proposed increase in dividend<\/span><\/a><\/p>\n","protected":false},"template":"","class_list":["post-123","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-report-interim","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","mfn-news-tag-mfn-report-interim-q4","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"es","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/es\/wp-json\/wp\/v2\/mfn_news\/123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/es\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/es\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/es\/wp-json\/wp\/v2\/media?parent=123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}